Supernus Pharmaceuticals (SUPN) Selling, General & Administrative (2011 - 2026)
Supernus Pharmaceuticals (SUPN) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | 133.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.64 Mn |
| Dec 31, 2025 | 122.39 Mn |
| Sep 30, 2025 | 179.68 Mn |
| Jun 30, 2025 | 93.55 Mn |
| Mar 31, 2025 | 89.94 Mn |
| Dec 31, 2024 | 79.41 Mn |
| Sep 30, 2024 | 69.75 Mn |
| Jun 30, 2024 | 85.90 Mn |
| Mar 31, 2024 | 86.52 Mn |
| Dec 31, 2023 | 81.28 Mn |
| Sep 30, 2023 | 82.70 Mn |
| Jun 30, 2023 | 86.78 Mn |
| Mar 31, 2023 | 85.60 Mn |
| Dec 31, 2022 | 73.97 Mn |
| Sep 30, 2022 | 112.31 Mn |
| Jun 30, 2022 | 100.48 Mn |
| Mar 31, 2022 | 90.46 Mn |
| Dec 31, 2021 | 101.74 Mn |
| Sep 30, 2021 | 72.03 Mn |
| Jun 30, 2021 | 69.54 Mn |